NCT00229112View on ClinicalTrials.gov

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Foot Infections in Diabetic Patients
Interventions
DRUG

MK0826, ertapenem sodium / Duration of Treatment - 24 weeks

DRUG

Comparator: Piperacillin/Tazobactam / Duration of Treatment - 24 weeks

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00229112 - Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034) | Biotech Hunter | Biotech Hunter